ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.933,62
1,56%
S&P 500
6.047,15
0,81%
Dow Jones
44.782,00
-0,29%
Euro vs US Dollar
1,04858
-0,14%
Bitcoin
95.980,38
0,12%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Elutia Inc (ELUT)

  7. Elutia Inc (ELUT) News

ELUT

Elutia (ELUT)

Elutia Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ELUT
DatumZeitQuelleÜberschriftSymbolFirma
02/12/202414h00GlobeNewswire Inc.Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.NASDAQ:ELUTElutia Inc
14/11/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
14/11/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
14/11/202422h05GlobeNewswire Inc.Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025NASDAQ:ELUTElutia Inc
13/11/202422h05GlobeNewswire Inc.Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:ELUTElutia Inc
29/10/202421h05GlobeNewswire Inc.Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024NASDAQ:ELUTElutia Inc
23/10/202422h05GlobeNewswire Inc.Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30NASDAQ:ELUTElutia Inc
15/10/202412h59Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELUTElutia Inc
03/10/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
18/09/202414h00GlobeNewswire Inc.Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable DevicesNASDAQ:ELUTElutia Inc
06/09/202422h23GlobeNewswire Inc.Elutia Celebrates First YearNASDAQ:ELUTElutia Inc
05/09/202422h05GlobeNewswire Inc.Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and NeurostimulatorsNASDAQ:ELUTElutia Inc
03/09/202422h05GlobeNewswire Inc.Elutia to Participate in Upcoming Investor ConferencesNASDAQ:ELUTElutia Inc
13/08/202415h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
13/08/202415h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
07/08/202422h05GlobeNewswire Inc.Elutia Announces Second Quarter 2024 ResultsNASDAQ:ELUTElutia Inc
07/08/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
01/08/202422h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
01/08/202422h05GlobeNewswire Inc.Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross ProceedsNASDAQ:ELUTElutia Inc
31/07/202422h05GlobeNewswire Inc.Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of OperationsNASDAQ:ELUTElutia Inc
30/07/202422h05GlobeNewswire Inc.Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024NASDAQ:ELUTElutia Inc
11/07/202422h05GlobeNewswire Inc.Elutia to Present at the Emerging Growth Conference on Thursday, July 18NASDAQ:ELUTElutia Inc
18/06/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202414h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
17/06/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202414h01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
17/06/202414h00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
10/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
10/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
10/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT

Kürzlich von Ihnen besucht

BOV
A1AP34
Advance Auto Parts
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€